Beyond A1c: A Course on Type 1 Diabetes Care and Management


T1D care and management is more than monitoring A1c. Access timely education and resources to adjust insulin therapy, select and use technologies, and prevent common complications through this self-paced multi-module course.

Modules consist recorded presentations from "Endocrine Fellows Series: Type 1 Diabetes Care and Management" conferences, clinical case vignettes with answer rationales, references, and additional resources. The modules are:

Optimizing Multiple Daily Injection Therapy
Jennifer Sherr, MD, PhD, Yale School of Medicine

Practical Considerations and Approaches to Data Management
Irl B. Hirsch, MD, University of Washington

Insights into Insulin Pump Therapy
Janet McGill, MD, Washington University-St. Louis

Applying CGM in Practice
Luisa Duran, MD, John Muir Health

Hypoglycemia in T1D: Risks and Practical Prevention Strategies
Elizabeth Seaquist, MD, University of Minnesota 

Exercise Management in T1D
Michael C. Riddell, PhD, York University

Screening and Managing Microvascular Disease in T1D
Janet McGill, MD, Washington University-St. Louis

Target Audience

This program will be of substantial interest to: endocrinologists and endocrine fellows, and pediatric endocrinologists and pediatric endocrine fellows. There is also interest among additional audiences of primary care and internal medicine physicians, physician’s assistants, nurse practitioners, and other healthcare professionals caring for individuals with type 1 diabetes.

Learning Objectives

Upon completion of this educational activity, participants will be able to (or better able to):

  • Devise individualized insulin therapy strategies to manage individuals with T1D
  • Incorporate diabetes technology into treatment strategies for appropriate individuals with T1D
  • Recognize and evaluate individuals with T1D for signs of microvascular disease
  • Apply updated knowledge of treatments, practice guidelines, and clinical skills to improve hypoglycemia prevention and exercise management

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Educator/Teacher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Diabetes and Glucose Metabolism
General Endocrinology
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Level 5 (Performance (Does))
Activity summary
Available credit: 
  • 6.00 ABIM MOC
  • 6.00 AMA PRA Category 1 Credits
  • 6.00 CME Certificate of Participation
Course opens: 
05/31/2019
Course expires: 
05/31/2020
Rating: 
5

PROGRAM DIRECTORS

Irl B. Hirsch, MD; University of Washington Sch of Med
Linda M. Siminerio, RN, PhD, CDE; University of Pittsburgh Diabetes Institute

CONTRIBUTING FELLOW

Jean Pujals-Kury, MD, SUNY Downstate Medical Center

PRESENTATION FACULTY

Luisa A. Duran, MD, John Muir Health
Irl B. Hirsch, MD, University of Washington Sch of Med
Janet B.McGill, MD, MA, FACE, Washington University in St. Louis
Elizabeth Seaquist, MD, University of Minnesota
Jennifer Sherr, MD, PhD, Yale School of Medicine
Michael C. Riddell, PhD, York University

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Irl B. Hirsch, MD, has served as a consultant to Abbott Diabetes Care; Becton, Dickinson and Company; Bigfoot Biomedical, Inc.; and Roche; and has received research support from Medtronic Diabetes.
Janet B. McGill, MD, has served as a consultant to Bayer, Gilead, Novo Nordisk Inc., and Sanofi; has received research support from Dexcom, Jaeb Center for Health Research, Medtronic, Novartis, and Sanofi; has served as a speaker for Aegerion, Dexcom, Janssen, and Mannkind.
Michael C. Riddell, PhD, has served as an advisory board member and/or speaker for Ascensia Diabetes Care, Eli Lilly and Company, Insulet Corporation, Medtronic; received grant support from Insulet Corporation; and received research support from Novo Nordisk and Sanofi.
Elizabeth Seaquist, MD, has served as an advisor to Eli Lilly and Company; has served as a consultant to Eli Lilly and Company, Mannkind Corporation, Sanofi, and Zucara; has received research support from Eli Lilly and Company; and has served as a sponsor of the International Hypoglycemia Study Group supported by Novo Nordisk Inc.
Jennifer Sherr, MD, PhD, has served as an advisory board member to Bigfoot Biomedical Inc., Eli Lilly and Company, and Insulet Corporation; has served as a consultant to Lexicon, Medtronic Diabetes, and Sanofi Aventis; and has served as a research investigator for Insulet Corporation and Medtronic Diabetes.

The following faculty reported no relevant financial relationship: Jean Pujals-Kury, MD and Luisa A. Duran, MD.

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMER

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

Use of professional judgment: 
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

Drugs and dosages:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

This educational activity is supported by a grant from the following supporters: Abbott Diabetes Care Inc.; Dexcom, Inc.; The Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; and Novo Nordisk Inc.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Review your Diplomate ABIM ID Number(s)

In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

Provide your board-certification information in your educational profile.  Your profile currently contains the following board ID numbers (must be logged in to view):

Your ABIM Number: [current-user:profile-profile:field-number-abim]*

*If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.

Update Profile

Available Credit

  • 6.00 ABIM MOC
  • 6.00 AMA PRA Category 1 Credits
  • 6.00 CME Certificate of Participation

Accreditation Period

Course opens: 
05/31/2019
Course expires: 
05/31/2020

Click Start to begin.

The course is available at no cost to registered users of the Endocrine Society's Center for Learning. Registration is also available at no cost.